RPG Life Sciences Launches Naprosyn ES; First-of-its-Kind Combo in India
RPG Life Sciences launches Naprosyn ES, a first-in-India Naproxen-Esomeprazole combo for chronic pain. The pharmaceutical firm reported TTM revenue of ₹707.5 Cr.
ALFA News
Straight from the exchange filing
RPG Life Sciences launches Naprosyn ES, a first-in-India Naproxen-Esomeprazole combo for chronic pain. The pharmaceutical firm reported TTM revenue of ₹707.5 Cr.